These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23114898)

  • 1. Should patients with advanced chronic kidney disease and atrial fibrillation receive chronic anticoagulation?
    Clase CM; Holden RM; Sood MM; Rigatto C; Moist LM; Thomson BK; Mann JF; Zimmerman DL
    Nephrol Dial Transplant; 2012 Oct; 27(10):3719-24. PubMed ID: 23114898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis.
    Harel Z; Chertow GM; Shah PS; Harel S; Dorian P; Yan AT; Saposnik G; Sood MM; Molnar AO; Perl J; Wald RM; Silver S; Wald R
    Can J Cardiol; 2017 Jun; 33(6):737-746. PubMed ID: 28545622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
    Yang F; Chou D; Schweitzer P; Hanon S
    Europace; 2010 Dec; 12(12):1666-72. PubMed ID: 21045011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
    Kumar S; de Lusignan S; McGovern A; Correa A; Hriskova M; Gatenby P; Jones S; Goldsmith D; Camm AJ
    BMJ; 2018 Feb; 360():k342. PubMed ID: 29444881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin use and the risk of mortality, stroke, and bleeding in hemodialysis patients with atrial fibrillation.
    Kai B; Bogorad Y; Nguyen LN; Yang SJ; Chen W; Spencer HT; Shen AY; Lee MS
    Heart Rhythm; 2017 May; 14(5):645-651. PubMed ID: 28185918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
    Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
    BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis.
    Chan PH; Huang D; Yip PS; Hai J; Tse HF; Chan TM; Lip GY; Lo WK; Siu CW
    Europace; 2016 May; 18(5):665-71. PubMed ID: 26504109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation in dialysis patients: time to abandon warfarin?
    Brancaccio D; Neri L; Bellocchio F; Barbieri C; Amato C; Mari F; Canaud B; Stuard S
    Int J Artif Organs; 2016 May; 39(3):99-105. PubMed ID: 27079417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.
    Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P
    Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study.
    Friberg L; Benson L; Lip GY
    Eur Heart J; 2015 Feb; 36(5):297-306. PubMed ID: 24722803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro.
    McCullough PA; Ball T; Cox KM; Assar MD
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):2079-2084. PubMed ID: 27797888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and Safety of Warfarin in Dialysis Patients With Atrial Fibrillation: A Meta-Analysis of Observational Studies.
    Liu G; Long M; Hu X; Hu CH; Liao XX; Du ZM; Dong YG
    Medicine (Baltimore); 2015 Dec; 94(50):e2233. PubMed ID: 26683937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis.
    Zimmerman D; Sood MM; Rigatto C; Holden RM; Hiremath S; Clase CM
    Nephrol Dial Transplant; 2012 Oct; 27(10):3816-22. PubMed ID: 23114904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation.
    Yasaka M; Yamaguchi T
    CNS Drugs; 2001; 15(8):623-31. PubMed ID: 11524034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for stroke prevention in patients with atrial fibrillation.
    Howard PA
    Drugs; 1999 Dec; 58(6):997-1009. PubMed ID: 10651387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants?
    Vázquez E; Sánchez-Perales C; García-Cortes MJ; Borrego F; Lozano C; Guzmán M; Gil JM; Liébana A; Pérez P; Borrego MJ; Pérez V
    Int J Cardiol; 2003 Feb; 87(2-3):135-9; discussion 139-41. PubMed ID: 12559531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Eisenberg MJ; Rahme E; Humphries KH; Tu JV; Behlouli H; Guo H; Pilote L
    Circulation; 2014 Mar; 129(11):1196-203. PubMed ID: 24452752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Ahmad Y; Lip GY
    Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.